Since epigenetic gene silencing involving DNMTs and HDACs plays an important role in colon cancer progression, Moseley et al. [161] investigated the role of EGCG in combination with other DNMT and HDAC inhibitors in this type of cancer, which at the time was the second leading cause of cancer death in the United States. Here, DNMT1 is linked to colonic neoplasm.